Literature DB >> 16589461

A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS.

D W Woolley1, E Shaw.   

Abstract

Year:  1954        PMID： 16589461      PMCID： PMC527980          DOI： 10.1073/pnas.40.4.228

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  10 in total

1.  5-Hydroxytryptamine; pharmacological action and destruction in perfused lungs.

Authors:  J H GADDUM; C O HEBB; A SILVER; A A SWAN
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1953

2.  Serotonin content of some mammalian tissues and urine and a method for its determination.

Authors:  B M TWAROG; I H PAGE
Journal:  Am J Physiol       Date:  1953-10

3.  Antimetabolites of serotonin.

Authors:  D W WOOLLEY; E SHAW
Journal:  J Biol Chem       Date:  1953-07       Impact factor: 5.157

4.  Acute psychosis as a complication of hydralazine therapy in essential hypertension.

Authors:  M MOSER; J SYNER; S MALITZ; T W MATTINGLY
Journal:  J Am Med Assoc       Date:  1953-08-01

5.  The variable arterial pressure response to serotonin in laboratory animals and man.

Authors:  I H PAGE; J W MCCUBBIN
Journal:  Circ Res       Date:  1953-07       Impact factor: 17.367

6.  Yohimbine and ergot alkaloids as naturally occurring antimetabolites of serotonin.

Authors:  E SHAW; D W WOOLLEY
Journal:  J Biol Chem       Date:  1953-08       Impact factor: 5.157

7.  Circulatory effects of 5-hydroxytryptamine.

Authors:  G REID
Journal:  J Physiol       Date:  1952-12       Impact factor: 5.182

8.  Pharmacological actions of synthetic 5-hydroxytryptamine (serotonin, thrombocytin).

Authors:  G REID; M RAND
Journal:  Nature       Date:  1952-05-10       Impact factor: 49.962

9.  Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine.

Authors:  V ERSPAMER; B ASERO
Journal:  Nature       Date:  1952-05-10       Impact factor: 49.962

10.  A hormonal neurogenic vasopressor mechanism.

Authors:  R D TAYLOR; I H PAGE; A C CORCORAN
Journal:  AMA Arch Intern Med       Date:  1951-07
  10 in total
  66 in total

1.  SEROTONIN RECEPTORS. IV. SPECIFIC DEFICIENCY OF RECEPTORS IN GALACTOSE POISONING AND ITS POSSIBLE RELATIONSHIP TO THE IDIOCY OF GALACTOSEMIA.

Authors:  D W WOOLLEY; B W GOMMI
Journal:  Proc Natl Acad Sci U S A       Date:  1964-07       Impact factor: 11.205

2.  A NEUROPHARMACOLOGICAL INVESTIGATION ON HALLUCINOGENIC DRUGS. LABORATORY RESULTS VERSUS CLINICAL TRIALS.

Authors:  V G LONGO; D BOVET
Journal:  Acta Neurochir (Wien)       Date:  1964       Impact factor: 2.216

3.  THE INFLUENCE OF CHLORPROMAZINE ON THE METABOLISM OF 5-HYDROXYTRYPTAMINE IN THE MOUSE.

Authors:  A L BARTLET
Journal:  Br J Pharmacol Chemother       Date:  1965-04

4.  Biochemistry of schizophrenia.

Authors:  J R SMYTHIES
Journal:  Postgrad Med J       Date:  1963-01       Impact factor: 2.401

5.  Cholinergic and non-cholinergic transmission in the mammalian spinal cord.

Authors:  D R CURTIS; J W PHILLIS; J C WATKINS
Journal:  J Physiol       Date:  1961-09       Impact factor: 5.182

6.  [On normal values of hourly 5-hydroxyindolacetic acid in the urine in man and factors interrupting the measurements].

Authors:  R DEGKWITZ; R FROWEIN; E KIRBERGER; C KULENKAMPFF; U MOHS
Journal:  Klin Wochenschr       Date:  1962-03-15

7.  Behavioral effects of 5-hydroxytryptophan.

Authors:  M H APRISON; C B FERSTER
Journal:  Experientia       Date:  1960-04-15

8.  Recent experiments with injections of drugs into the ventricular system of the brain.

Authors:  W FELDBERG; S L SHERWOOD; D RICHTER
Journal:  Proc R Soc Med       Date:  1955-10

9.  Interaction of serotonin and lysergic acid diethylamide (LSD) in the central nervous system.

Authors:  P A SHORE; S L SILVER; B B BRODIE
Journal:  Experientia       Date:  1955-07-15

Review 10.  Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.

Authors:  Clint E Canal; Drake Morgan
Journal:  Drug Test Anal       Date:  2012-04-19       Impact factor: 3.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.